In collaboration with Payame Noor University and Iranian Society of Physiology and Pharmacology

Document Type : Article

Authors

1 Ph.D., Department of Biochemistry, Faculty of Science, Payam ‎Noor University, Tehran, Iran

2 Professor , Department of Biochemistry, Faculty of Science, ‎Payam Noor University, Tehran, Iran

3 Associate Professor, Department of Biotechnology, Institute of ‎Science, High Technology and ‎Environmental ‎Sciences,Graduate University of Advanced Technology, ‎Kerman, Iran

4 Associate Professor, Department of chemistry, Faculty of ‎Science, Payam Noor University, Tehran, Iran

Abstract

Urate oxidase or uricase (UOX) (EC 1.7.3.3) is an globular tetramer oxidoreductase enzyme which lacks cofactor. Much research on this enzyme has been done so far due to its biomedical applications as a therapeutic and diagnostic agent. Urate oxidase catalyzes uric acid degradation and produces allantoin. An imbalance in the excretion of uric acid causes the hyperuricemia. Part of a clinically important diagnostic kit used to measure the concentration of uric acid in the blood is the enzyme uricase. In this research, efforts are made to investigate the effect of triethylammonium maleate (TEAM) ionic liquid on the function of urate oxidase (UOX). Ionic liquids are salts with important properties like high thermal stability, high solvating capacity and high polarity. These salts have been considered in biochemical and biomedical fields. They can also be utilized as a stabilizer for long-term protein storage and they can extend the shelf life of some proteins such as therapeutic or industrial proteins. In this study, we treated the enzyme in different concentrations of triethylammonium maleate ionic liquid. The volume percentages of TEAM in the solvent phase are 1%, 2%, 5%, 10% and 15%. The results indicate that TEAM has a concentration-dependent effect on the activity of UOX enzyme. The use of 5% TEAM ionic liquid increased the enzymatic activity in comparison to untreated enzyme. We concluded that this ionic liquid was able to alter the structure of the uricase in a way that increased the activity and improve its catalytic efficiency of uricase.

Keywords

Alakel, N.; et al. (2017). Prevention and treatment of tumor lysis syndrome, and the efficacy and role of rasburicase. OncoTargets and therapy 10: 597.
Bayramoğlu, G.; et al. (2011). Reversible immobilization of uricase on conductive polyaniline brushes grafted on polyacrylonitrile film. Bioprocess and biosystems engineering; 34(2): 127-134.
Bihari, M.; et al. (2010). "Dissolution and dissolved state of cytochrome c in a neat, hydrophilic ionic liquid." Biomacromolecules; 11(11): 2944-2948.
Caves, M.S.; et al. (2013). Thermal inactivation of uricase (urate oxidase): mechanism and effects of additives. Biochemistry; 52(3): 497-507.
Chen, D.; et al. (2010). Low-Potential Detection of Endogenous and Physiological Uric Acid at Uricase- Thionine-Single-Walled Carbon Nanotube Modified Electrodes. Analytical chemistry; 82(6): 2448-2455.
Colloc'h, N.; et al. (1997). Crystal structure of the protein drug urate oxidase-inhibitor complex at 2.05 Å resolution. Nature structural biology; 4(11): 947-952.
Constatinescu, D.; et al. (2010). Patterns of protein unfolding and protein aggregation in ionic liquids. Physical Chemistry Chemical Physics; 12(8): 1756-1763.
Galani, D.; Apenten, R. K. O. (1997). The comparative heat stability of bovine β‐lactoglobulin in buffer and complex media. Journal of the Science of Food and Agriculture; 74(1): 89-98.
Hashemzadeh, H.; Raissi, H. (2018). Covalent organic framework as smart and high efficient carrier for anticancer drug delivery: a DFT calculations and molecular dynamics simulation study. Journal of Physics D: Applied Physics; 51(34): 345401.
Huang, S.-H.; et al. (2004). Detection of serum uric acid using the optical polymeric enzyme biochip system. Biosensors and Bioelectronics; 19(12): 1627-1633.
Imani, M.; Shahmohamadnejad, S. (2017). Recombinant production of Aspergillus Flavus uricase and investigation of its thermal stability in the presence of raffinose and lactose. 3Biotech;7(3): 1-9.
Jaeger, V.W.; Pfaendtner, J. (2016). Destabilization of human serum albumin by ionic liquids studied using enhanced molecular dynamics simulations. The Journal of Physical Chemistry B; 120(47): 12079-12087.
Kumari, M.; et al. (2014). Probing HSA-ionic liquid interactions by spectroscopic and molecular docking methods. Journal of Photochemistry and Photobiology B: Biology; 138: 27-35.
Li, W.; et al. (2017). Directed evolution to improve the catalytic efficiency of urate oxidase from Bacillus subtilis. PloSone; 12(5): e0177877.
Liao, F.; et al. (2006). Evaluation of a kinetic uricase method for serum uric acid assay by predicting background absorbance of uricase reaction solution with an integrated method. Journal of Zhejiang University Science B; 7(6): 497-502.
Liu, L.; Guo, Q.-X. (2001). Isokinetic relationship, isoequilibrium relationship, and enthalpy-entropy compensation. Chemical Reviews; 101(3): 673-696.
Lohrasbi‐Nejad, A.; et al. (2016). Hydrophobin‐1 promotes thermostability of firefly luciferase. The FEBS Journal; 283(13): 2494-2507.
Lou, W.Y.; Zong, M.H. (2006). Efficient kinetic resolution of (R, S)‐1‐trimethylsilylethanol via lipase‐mediated enantioselective acylation in ionic liquids. Chirality: The Pharmacological, Biological, and Chemical Consequences of Molecular Asymmetry; 18(10): 814-821.
Marin, E.; et al. (2003). Effect of heat treatment on bovine lactoperoxidase activity in skim milk: kinetic and thermodynamic analysis. Journal of Food Science; 68(1): 89-93.
Middleton, J.K.; et al. (2002). Thermostability of reovirus disassembly intermediates (ISVPs) correlates with genetic, biochemical, and thermodynamic properties of major surface protein μ1. Journal of virology; 76(3): 1051-1061.
Moore, J.B.; et al. (2014). The role of dietary sugars and de novo lipogenesis in non-alcoholic fatty liver disease. Nutrients; 6(12): 5679-5703.
Pession, A.; et al. (2008). Pitfalls, prevention, and treatment of hyperuricemia during tumor lysis syndrome in the era of rasburicase (recombinant urate oxidase). Biologics: targets & therapy; 2(1): 129.
Pui, C.-H.; et al. (2001). Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients with leukemia or lymphoma. Journal of clinical oncology; 19(3): 697-704.
Pui, C.; et al. (2001). Recombinant urate oxidase (rasburicase) in the prevention and treatment of malignancy-associated hyperuricemia in pediatric and adult patients: results of a compassionate-use trial. Leukemia; 15(10): 1505-1509.
Schumacher, H.R.; Chen, L.X. (2006). Newer therapeutic approaches: gout. Rheumatic Disease Clinics; 32(1): 235-244.
Sherman, M.R.; et al. (2008). PEG-uricase in the management of treatment-resistant gout and hyperuricemia. Advanced drug delivery reviews; 60(1): 59-68.
Shikha, S.; et al. (2017). Facile fabrication of lipase to amine functionalized gold nanoparticles to enhance stability and activity. RSC advances; 7(68): 42845-42855.
van Rantwijk, F.; et al. (2006). Structure and activity of Candida antarctica lipase B in ionic liquids. Green Chemistry; 8(3): 282-286.
Vasantha, T.; et al. (2012). Structural basis for the enhanced stability of protein model compounds and peptide backbone unit in ammonium ionic liquids. The Journal of Physical Chemistry B; 116(39): 11968-11978.
Zaboli, M.; Raissi, H. (2017). The influence of nicotine on pioglitazone encapsulation into carbon nanotube: the investigation of molecular dynamic and density functional theory. Journal of Biomolecular structure and dynamics; 35(3): 520-534.
Zhao, C.; et al. (2009). Highly sensitive and selective uric acid biosensor based on direct electron transfer of hemoglobin-encapsulated chitosan-modified glassy carbon electrode. Analytical Sciences; 25(8): 1013-1017.